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Malacoplakia is a form of chronic granulomatous inﬂammatory reaction that rarely aﬀects the pediatric age group. The
gastrointestinal system is the second most common site for the occurrence of malacoplakia. We report the case of a 9-year-
old girl who was hospitalized for abdominal pain, chronic diarrhea, and rectal hemorrhage. The endoscopic examinations and
histopathology conﬁrmed the diagnosis of intestinal malacoplakia. We successfully treated her with oral levoﬂoxacin. This disease
does not have any speciﬁc clinical or biological signs, and the diagnosis is exclusively based on histology.
1.Introduction
Malacoplakia is an acquired granulomatous disorder ﬁrst
described by Michaelis and Gutmann in 1902 [1]. It’s
believed to be caused by an alteration of the bacterial
phagocytic system [2]. Malacoplakia has been described
in numerous anatomic locations, most commonly in the
genitourinary tract. The gastrointestinal system, especially
the colon, is a second common site for the occurrence of
malacoplakia [3]. Clinically, it can mimic a neoplasm that
occurs in the form of a mass [4]. The diagnosis is exclusively
based on histology. The cardinal ﬁnding is the presence of
numerous histiocytes with pathognomonic intracellular and
extracellular Michaelis-Gutmann bodies [5].
2.CaseReport
A 9-year-old girl presented with history of abdominal pain,
prolonged diarrhea, and rectal bleeding. She presented cuta-
neous leishmaniasis at 3-year-old, diﬀuse verruca vulgaris,
recurrent skin, and respiratory infections.
She was hospitalised two years ago for pneumonia.
Physical examination found hepatosplenomegaly and cervi-
cal adenopathy. The only abnormal laboratory test was an
increase of γ-globulin count at 26,9g/L. Inﬂammatory and
infectious biological tests were normal. The humoral and
cellular immunity was normal.
Ultrasonography and computed tomographic scan of the
chest and abdomen showed numerous mesenteropelvic and
inguinal gonglions and homogenous hepatosplenomegaly.
The liver and the spleen had a size of 19cm and 12cm
respectively.
Biopsy of an adenopathy showed a non speciﬁc mixed
follicular and paracortical hyperplasia, with by place
eosinophil’s inﬁltration. The liver biopsy was normal.
The patient was lost to followup, and she was rehospi-
talized after two years. The physical examination revealed a
pale, cachectic girl whose spleen was palpable 2cm below
the left costal margin and the liver had a size of 12cm.
She had a numerous superﬁcial lymph nodes measuring
1cm. The rectal examination ached and revealed some
blood.
Thelaboratoryworkupshowedanormalleukocytecount
at 9700/mm3 with hypereosinophilia at 1700/mm3.T h e
haemoglobin and the platelet counts were normal. The
erythrocyte sedimentation rate was 26mm/hour, and the γ-
globulin was increased to 26,5g/L. The biologic hepatic and
renal functions were normal.2 ISRN Gastroenterology
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Figure 1: (a) Endoscopic view showing an extended colitis with edema and thickening of mucosa, (b) bleeding rectal polyp.
(a) (b)
Figure2:(a)Diﬀuseinﬁltrationofthecolonicmucosabynumeroushistiocyteswithcytoplasmicinclusions,(b)lesionwhichstainpositively
with periodic acid-Schiﬀ, Von Kossa, and Prussian blue stains: Michaelis-Gutmann bodies.
Wecompletedduringthishospitalizationtheexploration
with endoscopic examinations. The gastroscopy revealed
a normal stomach, multiple polypoid lesions measuring
0.2cm, and friable mucosa in duodenum. Multiple biopsy
specimens were taken. Microscopic examination showed
lymphoid hyperplasia.
The colonoscopy and rectoscopy revealed an extended
colitis with superﬁcial ulcerations, friable mucosa, and
bleeding rectal polyps measuring 2cm (Figure 1(a) and
1(b)).
The histopathological study showed a diﬀuse inﬁltra-
tion of the colonic mucosa by numerous histiocytes with
cytoplasmic inclusions (Figure 2(a)), which stain positively
with periodic acid-Schiﬀ, Von Kossa, and Prussian blue
stains(Figure 2(b)).HistiocyteshadcharacteristicMichaelis-
Gutmann bodies. The ﬁnal diagnosis was malacoplakia with
primary involvement of the gastrointestinal system.
The patient was treated with oral ﬂuoroquinolone
(Ciproﬂoxacin) 10mg/Kg × 2/day. The patient’s course was
uneventful, and she was followed well (5 months after start-
ing treatment). Diarrhea and rectal bleeding had stopped
and hepatosplenomegaly decreased. The colonoscopy was
controlled after two years of antibiotic treatment; we found
that inﬁltration and ulceration of intestinal mucosa had
decreased with a normal rectum (Figure 3). The histologic
examination showed a non speciﬁc inﬂammation without
Michaelis-Gutmann bodies.
Actually, the patient has a normal growth. The hep-
atosplenomegaly was present with normal biologic tests. The
follow up is of a three-year period.
3. Comments
Malacoplakia is a rare, histologically unique, chronic inﬂam-
matory reaction of various organs such as the urinary tract
and gastrointestinal system [3, 4]. The term “malacoplakia”,
meaning “soft” and “plaque” in Greek, was coined by Von
Hansemann in 1903 to describe yellowish tumor-like lesion
in the urinary bladder [3, 6]. Since 1902, approximately 400
cases of malacoplakia have been reported in the literature
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Figure 3: Endoscopic view after two years of treatment showing a
normal intestinal mucosa.
There is a bimodal age incidence, with one peak for
children below 13 years and second peak for middle-aged
adults [5]. The mean age at diagnosis was around the ﬁfth
decadeofage[2].Malacoplakiaisrareinchildrenandusually
involves the gastrointestinal tract, and is associated with
signiﬁcant additional systemic disease [8]. A female-to-male
preponderance of 4:1 is reported when the disease aﬀects
genitourinary system [2, 7]. In the other locations, male and
female patients were equally aﬀected [7].
Some authors emphasize the correlation between
immunosuppression and malacoplakia, because an
increasing number of cases in immunodeﬁcient individuals
and in patients receiving chemotherapy, has been reported
[5, 6]. Furthermore, malacoplakia has been correlated with
malignant neoplasms, systemic diseases, mycotic infections,
liver diseases, sarcoidosis, ulcerative colitis, cachexia, and
drug addiction [5]. In our case, the patient presented in her
clinical history a cutaneous leishmaniasis, diﬀuse verruca
vulgaris with recurrent skin, and respiratory infections, but
the humoral and cellular immunity were normal.
Themalacoplakiamayaﬀectmanyorgans,butfrequently
involves the urinary tract in 75% of cases [3, 4]. Other
locations were also described including the gastrointesti-
nal system, skin, soft tissue lung, bone, retroperitoneum,
spleen, pancreas, lymph nodes, brain, and liver [4, 5, 7].
The gastrointestinal tract being the second most frequent
location outside the urogenital tract; gastrointestinal and
retroperitoneal sites were each identiﬁed in 12% of cases [5].
In the majority of cases, the colorectum was the commonly
involved part [7]. Colonic malacoplakia was ﬁrst described
by Terner and Lattes in 1965 [4, 5]. The descending colon,
sigmoid, and rectum are common sites and can also involve
the upper tract [4]. In our case, the entire colon, the rectum,
and the duodenum were involved.
Clinical manifestations of colonic malacoplakia are non-
speciﬁc; rectal bleeding, diarrhea, abdominal pain, and fever
aretheusualpresentingsymptoms[5,9].Theendoscopycan
reveal three diﬀerent gross morphologic patterns reported
in cases of gastrointestinal malacoplakia; unifocal mucosal,
widespread multinodular or polypoid, and large mass
involving adjacent organs [3]. In the present case, the
endoscopy revealed superﬁcial ulcerations, friable mucosa,
and bleeding rectal and duodenal polyps.
Clinical presentation and endoscopic lesions, such uni-
focal nodules and polypoidal or mass lesions, can often
mimics a mistaken diagnosis of ulcerative colitis and car-
cinoma [3, 4]. The deﬁnitive diagnosis is exclusively based
on histopathologic examination; the cardinal ﬁnding is
the presence of numerous histiocytes with pathognomonic
intracellular and extracellular Michaelis-Gutmann bodies.
Theses bodies stain positively with periodic acid-schiﬀ,v o n
Kossa, and Prussian blue stains [3, 5].
Even after a century since the lesion was ﬁrst described,
the pathogenesis of malacoplakia remains unclear [4]. The
condition may result from incomplete bacterial killing and
digestion by phagocytic mononuclear cells, which leads to
accumulation of mononuclear cells or “Von Hansemann
cells” containing partially digested bacterial fragments [10,
11]. Incomplete bacterial killing and phagolysosomes with
subsequent deposits of iron and calcium constitutes inclu-
sions known as Michaelis-Gutmann bodies [9, 12].
The microorganisms most commonly cultured from
malacoplakia are gram-negative rods (Escherichia Coli, Kleb-
siella,a n dEnterobacter) and gram-positive cocci (Staphylo-
coccus aureus, Enterococcus, and several varieties of Strepto-
coccus)[ 13]. This postinfectious hypothesis was based on
constatation that 90% of malacoplakia involving genitor-
urinary tract were associated with coliform infection, and in
72%ofcasesthemicroorganismwasanEscherichiaColi[14].
It has been suggested that there is an abnormal
macrophage response with defective lysosomal function [4].
Some studies have demonstrated low levels of cyclic guano-
sine monophosphate in the monocytes of these patients
[5]. This decreased level may interfere with microtubular
and lysosomal activity, leading to incomplete elimination
of bacteria from macrophages [4]. In conclusion, the
pathogenesis of malacoplakia includes two factors: bacterial
infectionanddisorderofimmunologicsystem.Inthepresent
case, the patient had a history of cutaneous leishmaniasis
and recurrent infections, but the immunity exploration was
normal.
Because malacoplakia of the gastrointestinal tract is rare,
treatment is based mainly on anecdotal reports. Therapy
has been both pharmacologic and surgical [3]. Medical
therapy consists of treatment with antibiotics, using drugs
that easily permeate the macrophage and destroy undigested
bacteria such as quinolones, rifampicin, and trimethoprim-
sulfamethoxasole [4, 15, 16]. Actually, Ciproﬂoxacin is pre-
ferred with approximately 90% of success versus 10% with
trimethoprim-sulfamethoxazole [5, 6]. Cholinergic agents,
such as bethanechol, were used in order to raise intracellular
levels of cyclic guanosine monophosphate in macrophages.
This conservator treatment is indicated when the involved
organ has been not deﬁnitively undamaged.
Although the response to therapy is unpredictable,
patients may respond if the treatment is continued on a
long-term basis, in order to prevent the recurrence and the
extension of diseases [6]. In our case, the child was treated
with oral ﬂuoroquinolone with a clinical and histological4 ISRN Gastroenterology
improvement after two years of treatment. In cases of
progressive lesion or no response to medical treatment, the
surgical resection may be the other choice of treatment [4–
6].
4. Conclusion
Malacoplakia is rarely reported in children and usually
involves the gastrointestinal tract in this age. This disease
does not have any speciﬁc clinical or laboratory signs and
the diagnosis is exclusively based on histology. The intestinal
malacoplakia may be more common than usually suspected,
especially in immunodeﬁcient patients. It must be ruled out
ineverypatienthavingchronicbloodyandmucousdiarrhea.
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